Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial
Hoffmann-La Roche
Lihua E Budde; Huilai Zhang; Won-Seog Kim; Dai Maruyama; Eduardo M Rego; Lalita Norasetthada; Huangming Hong; Muhit Ozcan; Young-Woo Jeon; Danielle Leão Cordeiro de Farias; Laura Maria Fogliatto; Astrid Pavlovsky; Hideki Goto; Adam J Olszewski; Nikesh Shah; Bei Hu; Shen Yin; Hao Wu; Iris To; Wahib S Ead; Joan Ashby; Martin Janousek; Song Pham; Jue Wang; Antonia Kwan; Connie L Batlevi; Michael C Wei; Jason Westin